AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Artificial Cells for Advanced Drug Delivery

Technology Benefits

Main Advantages of this InventionΓÇó Effective delivery of the drug through the biological barriersΓÇó No need to chemically alter the drugΓÇó Administered intravenously

Technology Application

Potential Areas of Application ΓÇó Drug therapeuticsΓÇó Drug development

Detailed Technology Description

None

Supplementary Information

Patent Number: US20140141089A1
Application Number: US2010704416A
Inventor: Liang, Hongjun
Priority Date: 11 Feb 2009
Priority Number: US20140141089A1
Application Date: 11 Feb 2010
Publication Date: 22 May 2014
IPC Current: A61K000914 | A61K0031337 | A61K00314745 | A61K00315415 | A61K00315513 | A61K0031573 | A61K0031635 | A61K003900 | A61K0039395 | A61P000304 | A61P000306 | A61P000310 | A61P000702 | A61P000906 | A61P000910 | A61P000912 | A61P001510 | A61P002508 | A61P002516 | A61P002518 | A61P002522 | A61P002524 | A61P002528 | A61P002702 | A61P002900 | A61P003104 | A61P003110 | A61P003112 | A61P003500
US Class: 424491 | 4241301 | 4241841 | 424498 | 514158 | 514180 | 514221 | 5142232 | 514283 | 514449
Assignee Applicant: Colorado School of Mines,Golden
Title: Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
Usefulness: Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
Summary: In the preparation of pharmaceutical composition for diagnosing and treating a disease or disorder (claimed) selected from breast cancer; prostate cancer; lung cancer; lymphomas; skin cancer; pancreatic cancer; colon cancer; melanoma; ovarian cancer; brain cancer; head and neck cancer; liver cancer; bladder cancer; non-small lung cancer; cervical carcinoma; leukemia; multiple sclerosis, neuroblastoma and glioblastoma; T and B cell mediated autoimmune diseases; inflammatory diseases; infections; hyperproliferative diseases; AIDS; degenerative conditions, cardiovascular diseases, and transplant rejection.
Novelty: Nanoparticle for diagnosing/treating a disease comprises porous framework core with porous framework material and compound; and lipid layer having transmembrane channel configured to release the compound, and is disposed on surface of core

Industry

Disease Diagnostic/Treatment

Sub Group

Cancer/Tumor

Country/Region

USA

For more information, please click Here